跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 7,656 条关于
“ARES X20+”
全部
7,656
临床试验
6,552
药物
586
机构
24
资讯
494
9天前
Cellipont and Xiogenix White Paper Shows Automated Fill-Finish Maintains Cell Viability Across 17-Fold Scale-Up
去年
MaaT013 Shows Promise in Phase 3 Trial for GI-aGvHD
去年
MaaT Pharma Completes Enrollment in Phase 3 Trial of MaaT013 for Acute Graft-versus-Host Disease
去年
MaaT Pharma's MaaT013 Shows Promising Data in Acute Graft-versus-Host Disease
5个月前
MaaT Pharma's Microbiome Therapy Shows 62% Response Rate in Severe Graft-versus-Host Disease
去年
MaaT Pharma's MaaT013 Shows Promising Long-Term Efficacy in Refractory GI-aGvHD
12天前
Novartis Heart Drug Pelacarsen Falls Short in Trials, Challenging Pipeline Strategy
2年前
Tislelizumab Approved in Europe for Non-Small Cell Lung Cancer Treatment
去年
MaaT Pharma Announces First U.S. Patient Treated with MaaT013 for aGvHD Under Expanded Access Program
9个月前
Moderna Faces Regulatory Headwinds as FDA Signals Stricter Vaccine Approval Standards
第 1 页,共 50 页
上一页
下一页